Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BDTX-1535 |
Trade Name | |
Synonyms | BDTX1535|BDTX 1535 |
Drug Descriptions |
BDTX-1535 is an irreversible fourth-generation EGFR inhibitor with activity against EGFR mutations, including mutations associated with resistance to third-generation inhibitors, which potentially reduces tumor growth (Eur J Cancer Vol 174, Supp 1:S14; Eur J Cancer, Vol 174, Supp 1:S22). |
DrugClasses | EGFR Inhibitor 4th gen 16 |
CAS Registry Number | NA |
NCIT ID | C187115 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BDTX-1535 | BDTX-1535 | 0 | 2 |
BDTX-1535 + Temozolomide | BDTX-1535 Temozolomide | 0 | 1 |